<DOC>
	<DOCNO>NCT00543543</DOCNO>
	<brief_summary>The purpose study evaluate safety , efficacy , immunogenicity V503 comparison GARDASIL . The primary hypothesis test study 1 ) V503 administer 16- 26-year-old adolescent young woman generally well-tolerated , 2 ) V503 reduces combine incidence Human Papillomavirus ( HPV ) Type 31/33/45/52/58-related disease compare GARDASIL , 3 ) V503 induce non-inferior geometric mean titer HPV Type 6/11/16/18 antibody compare GARDASIL .</brief_summary>
	<brief_title>Broad Spectrum HPV ( Human Papillomavirus ) Vaccine Study 16-to 26-Year-Old Women ( V503-001 )</brief_title>
	<detailed_description>The study include double-blind , dose-finding evaluation 3-dose regimen 3 dose formulation V503 GARDASIL ( Base Study Part A ) , double-blind , safety/efficacy evaluation 3-dose regimen V503 dose formulation select Part A GARDASIL ( Base Study Part B ) , open-label extension consist 2 substudies : evaluation immune memory participant receive fourth vaccination V503 ( Extension Cohort 1 ) opportunity participant receive GARDASIL base study receive 3-dose regimen V503 ( Extension Cohort 2 ) .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<mesh_term>Papillomavirus Infections</mesh_term>
	<mesh_term>Condylomata Acuminata</mesh_term>
	<mesh_term>Vaginal Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Female 16 26yearsold Has never Pap test normal Pap test result For immune memory substudy extension ( Cohort 1 ) : randomize V503 Part B base study perprotocol immunogenicity population ≥1 HPV type For 3dose V503 vaccination substudy extension ( Cohort 2 ) : randomize GARDASIL either Part A Part B base study receive ≥1 dose GARDASIL History abnormal cervical biopsy result History positive test HPV History external genital/vaginal wart Currently user illegal drug alcohol abuser History severe allergic reaction require medical attention Are pregnant Received market HPV vaccine participate HPV trial Currently enrol clinical trial Currently history certain medical condition currently take take certain medication ( detail discuss time consent . )</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>26 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>